Medicare Enrolled

Dr. Fiona Gupta, M.D.

Neurology · Oradell, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
680 KINDERKAMACK RD STE 300, Oradell, NJ 07649
2013422550
In practice since 2008 (18 years)
NPI: 1346409547 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gupta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gupta? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gupta

Dr. Fiona Gupta is a neurology specialist in Oradell, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Gupta performed 8,720 Medicare services across 596 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gupta received a total of $819,873 from 53 pharmaceutical and/or device companies across 1457 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gupta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 9% volume in NJ $819,873 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,720
Medicare services
Top 9% in NJ for neurology
596
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~484 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
7,500 $5 $16
Brain stimulator programming, additional 15 minutes
Electronic analysis and programming of an implanted brain neurostimulator generator by a qualified health professional. This code applies to each additional 15-minute increment beyond the initial service.
365 $40 $327
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
318 $108 $426
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
241 $155 $574
Brain stimulator programming, first 15 minutes
Electronic analysis of an implanted brain, spinal cord, or peripheral neurostimulator generator. This service includes programming the brain stimulator by a qualified health professional for the first 15 minutes.
162 $46 $336
New patient office visit, complex (60-74 min) 72 $175 $803
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
62 $82 $290
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$819,873
Total received (2018-2024)
Avg $117,125/year across 7 years
Top 1% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
1,457
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$622,144 (75.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$173,841 (21.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,888 (2.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$251,524
2023
$158,139
2022
$63,334
2021
$44,502
2020
$62,438
2019
$97,620
2018
$142,315

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Neurocrine Biosciences, Inc.
$109,597
MDD US Operations, LLC
$76,743
ACADIA Pharmaceuticals Inc
$35,914
Abbott Laboratories
$10,542
Amneal Pharmaceuticals LLC
$8,218
ABBVIE INC.
$5,565
Lundbeck LLC
$557
Teva Pharmaceuticals USA, Inc.
$514
PFIZER INC.
$494
Medtronic, Inc.
$427
VERTEX PHARMACEUTICALS INCORPORATED
$400
Halozyme Inc
$287
ARGENX US, INC.
$222
Saluda Medical Americas, Inc.
$218
Lilly USA, LLC
$215
Acorda Therapeutics, Inc
$207
Biogen, Inc.
$205
TG Therapeutics, Inc.
$158
UCB, Inc.
$154
InSightec,Inc
$146
HARMONY BIOSCIENCES LLC
$134
Ipsen Biopharmaceuticals, Inc
$109
Takeda Pharmaceuticals U.S.A., Inc.
$87
Eisai Inc.
$86
Currax Pharmaceuticals LLC
$66
Amgen Inc.
$65
Becton, Dickinson and Company
$45
REVANCE THERAPEUTICS, INC.
$40
Merz Pharmaceuticals, LLC
$36
Kyowa Kirin, Inc.
$28
Otsuka America Pharmaceutical, Inc.
$22
Bausch Health US, LLC
$22
Top 3 companies account for 88.4% of 2024 payments
All-time payments by company (2018-2024) ›
Neurocrine Biosciences, Inc.
$245,259
MDD US Operations, LLC
$93,707
ACADIA Pharmaceuticals Inc
$91,969
Abbott Laboratories
$91,093
Amneal Pharmaceuticals LLC
$71,043
Kyowa Kirin, Inc.
$33,230
Sunovion Pharmaceuticals Inc.
$31,811
Adamas Pharmaceuticals, Inc.
$27,029
US WorldMeds, LLC
$20,011
Neurocrine BioSciences, Inc.
$16,430
UCB, Inc.
$14,311
Acorda Therapeutics, Inc
$13,972
Merz North America, Inc.
$11,678
Ipsen Biopharmaceuticals, Inc
$8,009
Merz Pharmaceuticals, LLC
$7,303
Otsuka Pharmaceutical Development & Commercialization, Inc.
$7,300
MERZ NORTH AMERICA, INC.
$6,966
ABBVIE INC.
$5,877
AbbVie, Inc.
$4,581
Teva Pharmaceuticals USA, Inc.
$3,595
Medtronic, Inc.
$2,622
Vertex Pharmaceuticals Incorporated
$2,000
VERTEX PHARMACEUTICALS INCORPORATED
$1,692
Global Kinetics USA Corporation
$1,500
ZOLL Medical Corporation
$800
Medtronic USA, Inc.
$647
Lundbeck LLC
$557
PFIZER INC.
$494
Becton, Dickinson and Company
$445
Dr.Reddy's Laboratories,Inc.
$445
Boston Scientific Corporation
$371
Halozyme Inc
$287
Allergan, Inc.
$275
EMD Serono, Inc.
$250
Mallinckrodt LLC
$241
ARGENX US, INC.
$222
Saluda Medical Americas, Inc.
$218
Lilly USA, LLC
$215
BOSTON SCIENTIFIC CORPORATION
$211
Biogen, Inc.
$205
TG Therapeutics, Inc.
$158
InSightec,Inc
$146
HARMONY BIOSCIENCES LLC
$134
Allergan Inc.
$96
Takeda Pharmaceuticals U.S.A., Inc.
$87
Eisai Inc.
$86
Currax Pharmaceuticals LLC
$66
Amgen Inc.
$65
Journey Medical Corporation
$56
REVANCE THERAPEUTICS, INC.
$40
Otsuka America Pharmaceutical, Inc.
$22
Bausch Health US, LLC
$22
Vertical Pharmaceuticals, LLC
$21
Top 3 companies account for 52.6% of all-time payments
Associated products mentioned in payments ›
ACCUNET · ACTHAR · ACTIVA · ADUHELM · AJOVY · AMPYRA · AMYVID · APLENZIN · APOKYN · AUSTEDO · AVONEX · Apokyn · Austedo XR · BD Introsyte · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · CREXONT · Ceracade · DAXI · DBS IPGs · DUOPA · Deep Brain Stimulation · Duopa · Dysport · EMGALITY · Evoke · Exablate · Fintepla · GENERAL DBS · GOCOVRI · Gocovri · HYQVIA · INBRIJA · INFINITY · INGREZZA · ISTRADEFYLLINE · Infinity DBS Pulse Generators · KISUNLA · LATUDA · LEQEMBI · Leqembi · MYOBLOC · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Neuromodulation Dspsbls and Accs · Nourianz · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONZETRA XSAIL · OSMOLEX ER · Ongentys · PERCEPT PC BRAINSENSE · Percept · Proclaim Family of SCS IPGs · QULIPTA · REXULTI · RYTARY · Rystiggo · SENSIGHT · SKYCLARYS · SenSight · TYSABRI · UBRELVY · UPLIZNA · VERCISE · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · WAKIX · XEOMIN · XIENCE SKYPOINT · Xadago · Xeomin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in NJ.

Looking for a neurology specialist in Oradell?
Compare neurologists in the Oradell area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
1,208
Per 100K population
126.5
County median income
$123,715
Nearest hospital
VALLEY HOSPITAL
2.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gupta is a mixed practice specialist, with above-average Medicare volume (top 9% in NJ), with speaking/promotional industry engagement in the top 1% of NJ peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gupta experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Gupta performed 7,500 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gupta receive payments from pharmaceutical companies?
Yes. Dr. Gupta received a total of $819,873 from 53 companies across 1,457 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gupta's costs compare to other neurologists in Oradell?
Dr. Gupta's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gupta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →